Prostacyclin-synthesis-stimulating plasma factor in patients with different stages of hepatic coma.
In patients with acute hepatic coma the prostacyclin synthesis stimulating plasma factor is significantly enhanced. This increased activity has been verified by using various test systems. However, there is no correlation between the actual plasma factor activity and the coma stage, respectively. The increase of plasma factor activity in these patients might account at least in part for the increased bleeding tendency seen in these patients.
D000293:Adolescent; D000328:Adult; D000818:Animals; D001158:Arteries / Q000187:drug effects / Q000378:metabolism*; D001161:Arteriosclerosis / Q000378:metabolism; D004727:Endothelium / Q000378:metabolism; D011464:Epoprostenol / Q000096:biosynthesis* / Q000097:blood; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D006474:Hemorrhagic Disorders / Q000097:blood; D006501:Hepatic Encephalopathy / Q000097:blood*; D006801:Humans; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D013552:Swine; D013556:Swine, Miniature
D011464:Epoprostenol